申请人:Kali-Chemie Aktiengesellschaft
公开号:US04096141A1
公开(公告)日:1978-06-20
A benzodiazepine derivative of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkyl which may be a straight chain, branched chain or cyclic group and may also be substituted, R.sub.2 is halogen, free hydroxyl, esterified hydroxyl, etherified hydroxyl, nitrile, carboxyl or a derivative thereof or is thioalkyl, thioaryl or the group ##STR2## R.sub.3 and R.sub.4 in this group being the same or different and being hydrogen, acyl, aryl, alkyl, aralkyl, aryloxyalkyl which latter five groups may also be substituted, or wherein R.sub.3 and R.sub.4 are saturated or unsaturated, straight chain or branched alkyl and in which groups the several alkyl may be interconnected directly or through a hetero atom, which if the hetero atom is nitrogen may also be substituted, and in which formula I, A and B are phenyl or phenyl, substituted by nitro, trifluoromethyl, halogen, methylthio, alkyl or alkoxy; or a pharmaceutically acceptable acid addition salt of said benzodiazepine derivatives of formula I.
一种苯二氮平衍生物,其化学式为##STR1##其中R.sub.1是氢、低碳基,可以是直链、支链或环状基团,也可以是取代基;R.sub.2是卤素、自由羟基、酯化羟基、醚化羟基、腈基、羧基或其衍生物,或者是硫代烷基、硫代芳基或者##STR2##其中该基团中的R.sub.3和R.sub.4相同或不同,可以是氢、酰基、芳基、烷基、芳基烷基、芳氧基烷基,这后五个基团也可以是取代基,或者是R.sub.3和R.sub.4是饱和或不饱和的直链或支链烷基,其中多个烷基可以直接或通过杂原子相互连接,如果该杂原子是氮,则也可以被取代;在该式I中,A和B是苯基或取代的苯基,取代基可以是硝基、三氟甲基、卤素、甲硫基、烷基或烷氧基;或者是该式I的药物可接受的酸加合物。